Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus

Authors

Kimberly C. Claeys
Evan J. Zasowski, Touro University CaliforniaFollow
Trang D. Trinh
Anthony M. Casapao
Jason M. Pogue
Nitin Bhatia
Ryan P. Mynatt
Suprat S. Wilson
Crystal Arthur
Robert Welch
Robert Sherwin
Wasif Hafeez
Donald P. Levine
Keith S. Kaye
George Delgado
Christopher A. Giuliano
Robert Takla
Colleen Rieck
Leonard B. Johnson
Kyle P. Murray

Publication Date

3-27-2019

DOI

10.1007/s40121-019-0242-5

ISSN

2193-6382

Recommended Citation

Claeys, K. C., Zasowski, E. J., Trinh, T. D., Casapao, A. M., Pogue, J. M., Bhatia, N., Mynatt, R. P., Wilson, S. S., Arthur, C., Welch, R., Sherwin, R., Hafeez, W., Levine, D. P., Kaye, K. S., Delgado, G., Giuliano, C. A., Takla, R., Rieck, C., Johnson, L. B., … Rybak, M. J. (2019). Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus. Infectious Diseases and Therapy, 8(2), 199–208. https://doi.org/10.1007/s40121-019-0242-5

Comments

See the work itself for complete list of authors. See here.